Profound Medical
PROF
43 hedge funds and large institutions have $54.3M invested in Profound Medical in 2025 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 11 increasing their positions, 10 reducing their positions, and 6 closing their positions.
10% more repeat investments, than reductions
Existing positions increased: 11 | Existing positions reduced: 10
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
2% less funds holding
Funds holding: 44 → 43 (-1)
4.81% less ownership
Funds ownership: 41.53% → 36.73% (-4.8%)
17% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 6
26% less capital invested
Capital invested by funds: $73.7M → $54.3M (-$19.4M)
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $34K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
First Eagle Investment Management
New York
|
+$865K |
| 2 |
RA
Royce & Associates
New York
|
+$485K |
| 3 |
RMC
Ring Mountain Capital
Tiburon,
California
|
+$186K |
| 4 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$133K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$127K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Raymond James Financial
St Petersburg,
Florida
|
-$4.03M |
| 2 |
PMAM
Picton Mahoney Asset Management
Toronto,
Ontario, Canada
|
-$1.5M |
| 3 |
TIM
Timelo Investment Management
Aurora,
Ontario, Canada
|
-$1.21M |
| 4 |
LBA
Letko, Brosseau & Associates
Montreal,
Quebec, Canada
|
-$1.11M |
| 5 |
Alyeska Investment Group
Chicago,
Illinois
|
-$944K |
PROF Hedge Fund Activity: Q3 2025 in Review
43 of the 7,620 institutional investors tracked by Wall St. Rank reported a position in Profound Medical (PROF) for Q3 2025, worth a combined $54.3M — down 26% from $73.7M a quarter earlier.
Sellers outnumbered buyers: 6 funds closed out of PROF and 5 opened new positions — a net loss of 1 holder — while 10 trimmed existing stakes and 11 added.
The largest buyer was First Eagle Investment Management, adding an estimated $865K. The largest seller was Raymond James Financial, cutting an estimated $4.03M.
- 43 institutional investors held Profound Medical (PROF) as of Q3 2025, down from 44 in Q2 2025.
- Funds reported $54.3M of Profound Medical stock for Q3 2025, down 26% quarter-over-quarter.
- 5 funds opened new Profound Medical positions in Q3 2025 and 6 closed out, a net change of -1 holder.
- The largest Profound Medical buyer in Q3 2025 was First Eagle Investment Management, an estimated $865K added.
- The largest Profound Medical seller in Q3 2025 was Raymond James Financial, an estimated $4.03M sold.
Based on aggregated 13F filings for Q3 2025.